CClinicalTrials.gg
CompletedNCT07410338Updated Feb 13, 2026

Lateral Decubitus vs Traction in the Supine Position in Proximal Femoral Nailing. Is There a Huge Difference?

An interventional study of lateral decubitus postion during proximal femoral nailing for unstable intertrochnateric femur fractures and Proximal femoral nailing for unstable intertrochnateric femur fractures in supine psoition using traction table in Unstable Intertrochanteric Fracture, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-13.

Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is designed to compare two positions in the management of unstable intertrochanteric femur fractures. It's to compare the traditional supine position using a traction table and lateral decubitus. This study is designed to Compare between The accuracy of reduction In both methods, in addition,the radiological exposure and other secondary outcomes, like the blood loss, are compared.

Read the detailed description

To compare the fluoroscopic exposure time, quality of radiographic reduction, intra operative blood loss, setup time and surgical time between the lateral decubitus position and the use of a traction table in supine position in fixation of unstable intertrochanteric femur fractures by proximal femoral nail.

02

Conditions studied

  • Unstable Intertrochanteric Fracture

Keywords

  • Unstable intertrochanteric fracture
  • Proximal femoral nail
  • proximal femoral fractures
  • traction table
  • lateral decubitus
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Skeletally mature patients
  • Unstable intertrochanteric fracture ( AO/OTA type 31A2 \& 31A3 )

Exclusion criteria

Exclusion Criteria:

  • Patients unfit for surgery
  • Revision cases
  • Patients with multiple or pathological, neglected or open fractures.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
77 participants (actual)

Study arms

  • Active comparator
    Lateral postion during proximal femoral nailing for unstable intertrochnateric femur fractures

    Proximal femoral nailing in lateral decubitus position

    Procedure: lateral decubitus postion during proximal femoral nailing for unstable intertrochnateric femur fractures

  • Active comparator
    Supine postion using traction table in proximal femoral nailing intertrochanteric femur fractures

    Proximal femoral nailing in supine position using traction table

    Procedure: Proximal femoral nailing for unstable intertrochnateric femur fractures in supine psoition using traction table

Interventions

  • Procedurelateral decubitus postion during proximal femoral nailing for unstable intertrochnateric femur fractures

    different positions of the patient during the surgery

  • ProcedureProximal femoral nailing for unstable intertrochnateric femur fractures in supine psoition using traction table

    different positions for the proximal femoral nailing

05

What researchers measure

Primary outcomes

  1. Quality of radiographic reduction

    Optimum Tip-to-apex distance (TAD) is 25mm or less. * Normal femoral neck shaft angle between 125 and 145 degree. * The Baumgartner reduction quality criteria : - 1. Criterion one (alignment) : 1. Anterior posterior view : normal or slight valgus neck shaft angle 2. lateral view : less than 20 degree of angulation (Slight valgus means a valgus of no more 10 degrees) 2. Criterion two (displacement) : 1. Anterior posterior view: less than 4 mm of displacement of any fragment. 2. Lateral view: less than 4 mm of displacement of any fragment. 3. The reduction will be categorized as good if both criteria were met, acceptable if only one criterion was met, and poor if Neither criterion was met.

    Time frame: immediate postoperative

  2. Fluoroscopic exposure time

    The fluoroscopic exposure time is defined as: The total duration of fluoroscopy use in minutes during the set up and the surgical procedure.

    Time frame: intraoperative

Secondary outcomes

  1. Setup time

    The period between the moment of transfer of the patient from the anesthesia team to the surgical team till the time of incision. This period includes placement of the patient on the surgical table or the traction table, preparation, and draping. The reduction and use of fluoroscopy during the reduction will be included within this time frame.

    Time frame: Intraoperative

  2. Surgical time

    The time between the skin incision and the closure of the wound.

    Time frame: Intraoperative

06

Study locations

1 site
  • Ain Shams University Hospitals
    Cairo, 11566, Egypt
07

References and documents

Individual participant data

Plan to share: Undecided — Not decided yet

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07410338
Lead sponsor
Ain Shams University
Responsible party
Sponsor
First posted
Feb 13, 2026
Start date
Jun 30, 2024
Primary completion
Jul 30, 2025
Completion
Jul 30, 2025
Last update
Feb 13, 2026

Study contacts

Amr Ahmed Abd Elrahman Hasan, Professor of Orthopedics
study director · Department of Orthoepdics - Faculty of Medicine - Ain Shams University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion